Crossmark

Botulinum toxin therapy of hemifacial spasm: bilateral injections can reduce facial asymmetry

Crossref DOI link: https://doi.org/10.1007/s00415-018-8960-2

Published Online: 2018-07-09

Published Print: 2018-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Xiao, Libin

Pan, Lizhen

Li, Bing

Zhou, Yanwen

Pan, Yougui

Zhang, Xiaolong

Hu, Yong

Dressler, Dirk

Jin, Lingjing
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81500970)

Shuguang Program (14SG21)

Shanghai municipal commission of health and family planning (201440535)

Talent Development Foundation of Putuo district (2014-A-21)

Shanghai municipal medical and health excellent academic leaders training program (2017BR029)
License Information

Text and Data Mining valid from 2018-07-09
More Information

Article History

Received: 1 March 2018

Revised: 24 April 2018

Accepted: 23 June 2018

First Online: 9 July 2018

Compliance with ethical standards

:

: DD received honoraria for services provided to Allergan, Ipsen, Merz, Medytox, Syntaxin, Desitin, Abbvie, Medtronic, St Jude, Boston Scientific, Almirall, Bayer, Sun, Teva, UCB, IAB-Interdisciplinary Working Group for Movement Disorders. He is shareholder of Allergan and holds patents on botulinum toxin and botulinum toxin therapy. All other authors declare no financial or other conflicts of interest in relation to this research and its publication.